(Q83508652)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for the introduction of HPV vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

Ioana Anca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Francis André

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Mustafa Bakir

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Hanna Czajka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Zsófia Mészner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Nuran Salman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Pavol Simurka

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Vytautas Usonis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

20 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pediatrics

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

1031-1035

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19301033%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00431-009-0972-6

24 January 2020

exact match

0 references

cites work

Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening

1 reference

12 December 2020

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

1 reference

12 December 2020

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study

1 reference

12 December 2020

Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis

1 reference

12 December 2020

The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN).

1 reference

12 December 2020

Cost-effectiveness of HPV 16, 18 vaccination in Brazil

1 reference

12 December 2020

The epidemiology of human papillomavirus infections

1 reference

12 December 2020

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

1 reference

12 December 2020

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

1 reference

12 December 2020

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

1 reference

12 December 2020

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

12 December 2020

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

12 December 2020

Human papillomavirus infection: epidemiology and pathophysiology

1 reference

12 December 2020

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

12 December 2020

Cost-effectiveness of a potential vaccine for human papillomavirus

1 reference

12 December 2020

Human papillomavirus and cervical cancer

1 reference

12 December 2020

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

1 reference

12 December 2020

Burden of cervical cancer in Europe: estimates for 2004.

1 reference

12 December 2020

Human papillomavirus genotypes and HPV16 variants in penile carcinoma

1 reference

12 December 2020

Female genital warts.

1 reference

12 December 2020

The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain

1 reference

12 December 2020

1 reference

12 December 2020

Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix.

1 reference

12 December 2020

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

1 reference

12 December 2020

Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.

1 reference

12 December 2020

The causal relation between human papillomavirus and cervical cancer

1 reference

12 December 2020

Condom use and the risk of genital human papillomavirus infection in young women

1 reference

12 December 2020

Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles

1 reference

12 December 2020

Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: analysis of primary tumors and lymph nodes.

1 reference

12 December 2020

Prophylactic HPV vaccines

1 reference

12 December 2020

Model for assessing human papillomavirus vaccination strategies

1 reference

12 December 2020